ГоловнаArchive of numbers2023Volume 31, issue 3 (116)Features of clinical and neurological manifestations in patients suffered COVID-19
Title of the article Features of clinical and neurological manifestations in patients suffered COVID-19
Authors Mishchenko Vladyslav
Bokatuieva Viktoriia
Fysenko Anastasiia
Lehka Mariia
In the section MECHANISMS OF FORMATION AND MODERN PRINCIPLES OF TREATMENT OF NEUROLOGICAL DISORDERS
Year 2023 Issue Volume 31, issue 3 (116) Pages 34-38
Type of article Scientific article Index UDK 616.8-009:578.834.1 Index BBK -
Abstract DOI: https://doi.org/10.36927/2079-0325-V31-is3-2023-6

 The aim of the work was to study the gender characteristics of clinical and neurological manifestations in patients with chronic brain ischemia depending on the presence of vaccination. The main neurological complaints presented by patients with chronic cerebrovascular disorders after sufferred COVID-19 were identified, which made it possible to determine the characteristics and frequency of occurrence of individual complaints in men and women. Changes in neurological status data were carefully analyzed depending on gender characteristics and the presence of vaccination. Changes in the neurological status in the group of men were detected in the study of the motor, sensitive sphere, vestibular sphere, and in women — in the study of coordination and vestibular disorders depending on the presence of vaccination, which allows us to say that the absence of vaccination leads to an increase in the expressiveness of complaints and manifestations of neurological disorders regardless of gender in different age groups of patients.
Key words COVID-19, clinical and neurological disorders, vaccination, gender characteristics
Access to full text version of the article pdf download
Bibliography 1. To KK, Sridhar S, Chiu KH, Hung DL, Li X, Hung IF, Tam AR, Chung TW, Chan JF, Zhang AJ, Cheng VC, Yuen KY. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg Microbes Infect. 2021 Dec;10 (1):507-535. doi: 10.1080/22221751.2021.1898291. PMID: 33666147; PMCID: PMC8006950.
2. Mishchenko T. S., Mishchenko V. M. Nevrolohichni uskladnennia u patsiientiv z COVID-19. Psykhiatriia, nevrolohiia ta medychna psykholohiia, 2021. Vyp.16. S. 23—33. DOI: 10.26565/2312- 5675-2021-16-03. (In Ukrainian).
3. Caronna E, van den Hoek TC, Bolay H, Garcia-Azorin D, Gago-Veiga AB, Valeriani M, Takizawa T, Messlinger K, Shapiro RE, Goadsby PJ, Ashina M, Tassorelli C, Diener HC, Terwindt GM, Pozo-Rosich P. Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review. Cephalalgia. 2023 Jan;43 (1):3331024221131337. doi: 10.1177/03331024221131337. PMID: 36606562.
4. Sampaio Rocha-Filho PA. Headache associated with COVID-19: Epidemiology, characteristics, pathophysiology, and management. Headache. 2022 Jun;62 (6):650-656. doi: 10.1111/head.14319. Epub 2022 May 11. PMID: 35545780; PMCID: PMC9348060.
5. Garg RK. Spectrum of Neurological Manifestations in Covid- 19: A Review. Neurol India. 2020 May-Jun;68 (3):560-572. doi: 10.4103/0028-3886.289000. PMID: 32643664.
6. Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E. Neurological manifestations associated with SARSCoV- 2 and other coronaviruses: A narrative review for clinicians. Rev Neurol (Paris). 2021 Jan-Feb;177 (1-2):51-64. doi: 10.1016/j. neurol.2020.10.001. Epub 2020 Dec 16. PMID: 33446327; PMCID: PMC7832485.
7. Jafari Z, Kolb BE, Mohajerani MH. Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis. Can J Neurol Sci. 2022 Mar;49 (2):184-195. doi: 10.1017/cjn.2021.63. Epub 2021 Apr 12. PMID: 33843530; PMCID: PMC8267343.
8. Narożny W, Tretiakow D, Skorek A. Czy wirus SARS-CoV-2 może uszkadzać słuch i równowagę? [Can the SARS-CoV-2 virus damage human hearing and balance?]. Med Pr. 2021 Jun 30;72 (3):321-325. doi: 10.13075/mp.5893.01083. Epub 2021 Apr 2. PMID: 33835112. (In Polish).
9. Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, Melloni EMT, Furlan R, Ciceri F, Rovere-Querini P; COVID-19 BioB Outpatient Clinic Study group; Benedetti F. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020 Oct;89:594-600. doi: 10.1016/j.bbi.2020.07.037. Epub 2020 Jul 30. PMID: 32738287; PMCID: PMC7390748.
10. Hu Y, Chen Y, Zheng Y, You C, Tan J, Hu L, Zhang Z, Ding L. Factors related to mental health of inpatients with COVID-19 in Wuhan, China. Brain Behav Immun. 2020 Oct;89:587-593. doi: 10.1016/j.bbi.2020.07.016. Epub 2020 Jul 15. PMID: 32681866; PMCID: PMC7362867.
11. Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020 Jul;87:34-39. doi: 10.1016/j.bbi.2020.04.027. Epub 2020 Apr 13. PMID: 32298803; PMCID: PMC7152874.
12. Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020 Oct;89:531-542. doi: 10.1016/j.bbi.2020.05.048. Epub 2020 May 30. PMID: 32485289; PMCID: PMC7260522.